Distribution Partnering Terms & Agreements Studied in New Report by CurrentPartnering
16 Jan 2013 • by Natalie Aster
Comprehensive understanding and unprecedented access to the distribution partnering agreements entered into by the worlds leading biopharma companies are provided in new The “Distribution Partnering Terms and Agreements” report by CurrentPartnering.
Distribution Partnering Terms and Agreements
Published: December, 2012
Price: US$ 2,695.00
The report provides a detailed understanding and analysis of how and why companies enter distribution deals.
The majority of deals are multicomponent whereby the licensor offers a right to distribute the resultant product of the research collaboration. There are also numerous pure distribution deals whereby the products originator takes on a distribution partner in order to maximize a products presence in the marketplace.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of all distribution deals announced since 2009 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual distribution contract documents as submitted to the Securities Exchange Commission by companies and their partners.
More information can be found in the report “Distribution Partnering Terms and Agreements” by CurrentPartnering.
To order the report or ask for sample pages contact [email protected]